Don’t Squander the SpaceX Gift: Why Good Government, Hard People, and Real Competition Must Arrive Before the Medical Industrial Complex Collapses

Elon Musk has said he will give every child in America one share of SpaceX stock next year, routed through the Trump Accounts program. At recent prices, that is roughly a $10.5 billion transfer to about 72–73 million kids, drawn from a company now valued near $2 trillion after its June 2026 IPO.  The gift is real enough to matter. It is not large enough, by itself, to paper over decades of reckless public spending, structural medical overcharging, or the permanent administrative class that treats other people’s money as an infinite resource. Politics is management. The managers we choose will decide whether this windfall is invested or squandered.

The SpaceX Share and the Limits of Private Generosity

Musk posted the pledge on X on October 19, 2026: one of his SpaceX shares to every kid in America, “the first of many.” The shares were trading near $146–148. SpaceX had just reported third-quarter revenue of $14.6 billion, up 161 percent year-over-year, and the company carries a market capitalization around $2 trillion.  The transfer is large by ordinary standards and small relative to Musk’s holdings. It is also downstream of policy. SpaceX’s explosive growth came after regulatory barriers fell. Private capital and engineering solved problems that public aerospace processes had treated as permanent. The same sequence will have to occur in medicine if the cost structure is ever to break.

Gifting stock to children does not repeal the obligation of fiscal discipline at every level of government. Butler County has maintained that discipline for years. Nancy Nix, first as treasurer and now as auditor, and Mike McNamara as treasurer have kept the books in the black. I have disagreed with Nancy on restaurants, cars, sweaters, and larger political questions including Trump and Vance. None of that changes the observable fact that she understands money. When we talk about county finances, I get clear answers. That is what an auditor is for. Preference arguments can wait until after the numbers are settled.

Local People, Hard Times, and the Test of Character

I have known George Lang for a long time. He is one of Ohio’s stronger state senators and has been through serious political and legal pressure. Years ago, when I was in the middle of one of the more public controversies that have followed me, I held a strategy lunch at LaRosa’s in Liberty Township. Fifteen to twenty people showed up. George came. At the time he was a West Chester trustee, not yet a state representative or senator, and he had every conventional reason to stay away. Conventional wisdom said a rising figure should not sit down with the local radical. He came anyway, ate pizza, and talked. I have not forgotten it. In adult life, I have found that the people willing to show up when the cost is real are the ones you can trust later. Most others reveal themselves under pressure.

The same pattern appears with other local figures. I have had hard conversations with Ann Becker and with Darbi Boddy. Their positions have moved; mine have stayed more constant. I still speak with both when the subject is county or party direction. Art Sauerwein, the new Butler County Republican chair, is navigating a party that is shifting toward clearer Trump alignment after twenty years of more mixed leadership. That shift will be permanent or it will not. The practical question is whether the party represents the voters who show up or protects an internal preference for moderation those voters have already rejected. Sheriff Jones and I differ on operational style; I still recognize competence where it exists. Roger Reynolds, Thomas Hall, Jennifer Gross, and Michael Ryan each bring different vantage points. Good government requires finding the overlapping work that must be done even when the people involved are not identical in every preference.

My own operating rule has been consistent. People who threaten me, send letters, or try to force me into their preferred lane discover that the cost is not free. I cannot think of a case in my adult life where someone who moved against me didn’t eventually pay a price. That reputation is not an accident. It is the same discipline I applied while working the Jason Voorhees role at the Kings Island haunt: guests are protected by the attraction’s rules, yet the job is still to function within those constraints and produce the intended effect. Public life has similar constraints. I defend the position. The threats continue from people who treat disagreement as license for antagonism. The work continues anyway.

The Medical Cost Structure and the Coming Reckoning

The medical industry in its current form is not sustainable. Hospitals routinely bill hundreds of dollars to push a syringe that can be purchased for a few dollars at a retail pharmacy. One documented case involved $722 charges for each IV push; the medication itself was billed separately.  Facility fees, chargemaster markups, and billing the same service at hospital rates when performed in an office setting have produced multiples of Medicare reference prices. Large health systems have built entire hillsides of facilities—visible near Bridgewater Falls looking toward the Cincinnati airport—on the assumption that the current reimbursement model continues indefinitely.

I have turned down high-paying offers inside that system because continued public criticism of it was worth more to me than the salary. Many people take the money. The salary structure rests on the post-2010 Affordable Care Act architecture and the expectation of perpetual third-party payment. X-ray technicians and other roles routinely clear six figures. The economic incentive is to keep patients in treatment pathways rather than to eliminate the underlying condition. Shopping malls once looked permanent too. When the cost structure became indefensible, and alternatives appeared, the physical footprint emptied. The same sequence is available in medicine once competitive models are allowed to scale.

Cures for major cancers are closer than the current billing regime admits. Recent work at UCLA and elsewhere has shown methods for producing renewable, off-the-shelf engineered immune cells that can attack solid tumors, reprogram stem cells to generate ongoing T-cell responses, and reduce the cost and customization barriers that have limited CAR-T approaches.  These are not yet standard of care. They are evidence that the technical path exists. The political and reimbursement path does not. Radiation and chemotherapy remain the default for many late-stage patients because the payment system rewards ongoing intervention. Friends of mine who are in stage-three and stage-four treatment have been told to hold on. The practical advice is the same: stay alive long enough for the competitive models to clear the regulatory and payment obstacles. That clearance requires elected officials who will not protect the existing revenue streams.

Good People, Hard Conditions, and the Management of Growth

Easy money has corrupted incentives across multiple sectors. People who know a three-dollar item is billed at two hundred dollars and still collect a paycheck participate in a system that delays better outcomes. The same pattern appears in any protected administrative layer: the work becomes the protection of the process rather than the production of the result. SpaceX grew because it lowered barriers and enforced engineering standards. Medicine will require an equivalent reduction in barriers and an equivalent insistence on measurable outcomes.

Good government comes from good people who have already survived hard conditions. The LaRosa’s lunch, the haunt work, the machine-shop years, and the periods of public controversy all tested the same question: who shows up when the cost is real and who disappears. Butler County has a concentration of people who have demonstrated fiscal competence and willingness to absorb political heat. Nancy Nix’s record on the numbers is one example. George Lang’s decision to attend an unpopular meeting is another. Those traits are not universal in politics. They are also not optional if the SpaceX-era wealth is to become lasting productive capacity rather than get absorbed by the next round of administrative expansion.

Trump will not be in office indefinitely. The question of continuity—whether through Vance or another figure—will be settled by whether the underlying incentives have been altered. A county party that aligns more closely with the voters who delivered the recent results is better positioned to defend those changes than one that treats them as temporary. The medical cost collapse will arrive whether local officials prepare for it or not. The difference will be whether replacement models are allowed to form here or whether revenue protection continues until the facilities empty, as the malls did.

The private gift of SpaceX shares is a useful transfer. It does not replace the requirement for managers who can keep public books in the black, tolerate disagreement without treating it as grounds for destruction, and clear the path for competitive innovation in sectors that have been protected too long. You can identify those managers by their behavior under pressure. The rest is preference. The numbers are not.

Footnotes

1.  Musk’s October 19, 2026 statement on X committed one SpaceX share per American child, to be delivered via Trump Accounts. Census estimates place the under-18 population near 72–73 million. At contemporaneous share prices of approximately $146–148, the notional value was roughly $10.5 billion. SpaceX’s post-IPO market capitalization has fluctuated near $2 trillion.

2.  SpaceX’s third-quarter 2026 revenue was reported at $14.58 billion, a 161 percent year-over-year increase. Analyst targets vary widely; Bernstein raised its target to $268, while the stock traded near $149 in late October.

3.  Documented hospital billing examples include $722 charges solely for the act of an IV push (medication billed separately) and systematic multiples of Medicare rates through facility fees and chargemaster pricing. Hospitals have also billed office-based services at hospital outpatient rates, producing large differentials on identical procedures.

4.  UCLA and related groups have published methods for generating renewable engineered immune cells from stem cells, off-the-shelf CAR-NKT and similar platforms capable of attacking solid tumors, and approaches that reduce per-patient customization costs. These remain largely preclinical or early-stage; they illustrate technical feasibility rather than immediate clinical availability.

5.  Butler County’s multi-year record of operating in the black under Nix (treasurer then auditor) and McNamara (treasurer) is a matter of public financial reporting. Preference disagreements on non-fiscal questions do not alter the observable management of county resources.

6.  The LaRosa’s Liberty Township lunch occurred during a period of elevated local controversy. Attendance by a then-township trustee who later became a state senator is cited as an instance of behavior under conditions where conventional incentives favored absence.

Bibliography & Further Reading

•  Hoffman, Rich. The Gunfighter’s Guide to Business.

•  Bloomberg, Wall Street Journal, New York Times, and Axios coverage of the October 19, 2026 Musk SpaceX share pledge and Trump Accounts mechanism.

•  SpaceX public financial reporting and analyst notes on Q3 2026 results (revenue, market capitalization).

•  NPR and KFF Health News reporting on hospital chargemaster practices, IV-push fees, and facility-fee differentials.

•  Patient Rights Advocate and related analyses of medical billing error rates and markups relative to Medicare reference prices.

•  UCLA Health and OncLive summaries of stem-cell-derived and off-the-shelf engineered immune-cell platforms for solid tumors (2025–2026 publications).

•  Ohio Auditor of State and Butler County financial reports on multi-year operating balances.

The private capital is arriving. Public managers will decide whether to use or consume it. In the age of disclosure, the distinction remains measurable.

Rich Hoffman

More about me

Click Here to Protect Yourself with Second Call Defense https://www.secondcalldefense.org/?affiliate=20707

About the Author: Rich Hoffman

Rich Hoffman is an author, political consultant, and strategic advisor based in Cincinnati, Ohio, and the creator of The Politics of Heaven—a unique framework that connects biblical theology, ancient history, and modern power structures to explain how moral alignment and spiritual forces shape global events. Blending real-world political experience with deep research into archaeology, UFO phenomena, and suppressed historical narratives, Hoffman offers compelling commentary on topics ranging from ancient civilizations and the Dead Sea Scrolls to modern populist movements, paranormal continuity, and leadership strategy in chaotic environments. As the author of The Gunfighter’s Guide to Business and the forthcoming Politics of Heaven, he brings a grounded yet provocative voice to media discussions, supported by firsthand experiences and a cross-disciplinary approach that bridges science, history, and theology. For interviews, speaking engagements, or expert analysis, visit richhoffmanbooks.com or contact directly via phone at 513-307-5815 or email at rhoffman@richhoffmanbooks.com.  If you’ve seen the movie, Disclosure Day and want to talk about it and the implications of Presidnet Trump’s UAP disclosures, let me know and we can bring some color to your coverage. https://richhoffmanbooks.com/media-inquiries-broadcast-topics-and-contact-info/?frame-nonce=ad51e7ecba I do have a firsthand UFO encounter to discuss.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.